Compare AUR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUR | ASND |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | Denmark |
| Employees | 1900 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 14.7B |
| IPO Year | N/A | 2014 |
| Metric | AUR | ASND |
|---|---|---|
| Price | $7.08 | $247.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 16 |
| Target Price | $9.43 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 29.5M | 643.1K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $407.30 | $96.35 |
| Revenue Next Year | $1,134.58 | $44.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.60 | $156.56 |
| 52 Week High | $8.57 | $250.74 |
| Indicator | AUR | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 57.84 | 59.56 |
| Support Level | $5.17 | $215.18 |
| Resistance Level | $8.57 | N/A |
| Average True Range (ATR) | 0.55 | 9.56 |
| MACD | -0.09 | 1.04 |
| Stochastic Oscillator | 30.00 | 92.11 |
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.